News

Two Studies Find Beta-Blockers Help Combat Breast Cancer Progression


 

FROM JOURNAL OF CLINICAL ONCOLOGY

Dr. Barron and his colleagues declared that they had no financial disclosures relevant to their study, which was funded by the Irish government. Dr. Melhem-Bertrandt and colleagues said they had no financial disclosures relevant to their study, which was supported by a grant from the National Institutes of Health. Dr. Ganz and Dr. Cole, who were supported by the Breast Cancer Research Foundation, the Jonsson Comprehensive Cancer Center Foundation, Susan G. Komen for the Cure, and the National Cancer Institute, also declared that they had no relevant financial disclosures.

Pages

Recommended Reading

Techniques Compared for Breast Tumor Detection
Breast Cancer ICYMI
Clinical Trial Participation Tied to Improved Breast Cancer Outcomes
Breast Cancer ICYMI
Bone Micrometastases Show No Survival Impact in Early Breast Cancer
Breast Cancer ICYMI
NCCN Breast Guidelines Stand by Bevacizumab
Breast Cancer ICYMI
Sequencing Reveals MAP3K1 Mutation in Luminal-Type Breast Cancer
Breast Cancer ICYMI
Radioactive Seeds Guide Surgeons to Nonpalpable Breast Lesions
Breast Cancer ICYMI
Genentech Appeals to FDAs Regulatory Flexibility on Avastin
Breast Cancer ICYMI
CDER: Avastin Breast Cancer Claim Undermines Approval Process
Breast Cancer ICYMI
Low Vitamin D Associated With Poor Prognostic Features in Breast Cancer
Breast Cancer ICYMI
Point/Counterpoint: Does Surgery Improve Survival in Stage IV Breast Cancer?
Breast Cancer ICYMI